原发性干燥综合征与系统性红斑狼疮共享两种免疫细胞特征的分层研究
该研究对45例原发性干燥综合征、29例系统性红斑狼疮、14例继发性干燥综合征及31例健康对照进行29种免疫细胞亚群流式分析,发现两种疾病具有相似的免疫架构,并可通过8种T细胞亚群特征高精度区分两种内型,且两种内型5年内损伤评分与疾病活动度变化不同。
要点
- 原发性干燥综合征与系统性红斑狼疮虽临床表现不同,但免疫细胞架构相似。
- 基于K-means聚类可识别跨越诊断的两种免疫内型。
- 8种T细胞亚群特征可高精度区分两种内型(AUC 0.9979)。
核心结论
- 原发性干燥综合征与系统性红斑狼疮患者存在共享的免疫细胞特征,可据此分层为两种内型。
研究设计与样本
- 研究纳入45例原发性干燥综合征、29例系统性红斑狼疮、14例系统性红斑狼疮相关继发性干燥综合征患者及31例性别匹配健康对照,均为低疾病活动度或临床缓解状态。
- 采用流式细胞术检测29种免疫细胞亚群,并使用监督机器学习、逻辑回归及K-means聚类分析。
主要发现
- 原发性干燥综合征与系统性红斑狼疮患者具有相似的免疫架构,尽管临床表现和预后不同。
- 对合并队列进行K-means聚类分析识别出两种跨越诊断的免疫内型。
- 逻辑回归和机器学习模型识别出8种T细胞亚群特征可高精度区分两种内型,曲线下面积为0.9979。
- 临床轨迹分析显示两种内型从基线至5年的损伤评分和疾病活动度变化不同。
关键数值与推荐
- 8种T细胞亚群特征区分两种内型的曲线下面积为0.9979。
临床怎么用
- 基于免疫细胞内型的分层策略可能有助于为原发性干燥综合征和系统性红斑狼疮患者选择靶向治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Similarities in the clinical and laboratory features of primary Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) have led to attempts to treat patients with primary SS or SLE with similar biologic therapeutics. However, the results of many clinical trials are disappointing, and no biologic treatments are licensed for use in primary SS, while only a few biologic agents are available to treat SLE patients whose disease has remained refractory to other treatments. With the aim of improving treatment selections, this study was undertaken to identify distinct immunologic signatures in patients with primary SS and patients with SLE, using a stratification approach based on immune cell endotypes. METHODS: Immunophentyping of 29 immune cell subsets was performed using flow cytometry in peripheral blood from patients with primary SS (n = 45), patients with SLE (n = 29), and patients with secondary SS associated with SLE (SLE/SS) (n = 14), all of whom were considered to have low disease activity or be in clinical remission, and sex-matched healthy controls (n = 31). Data were analyzed using supervised machine learning (balanced random forest, sparse partial least squares discriminant analysis), logistic regression, and multiple t-tests. Patients were stratified by K-means clustering and clinical trajectory analysis. RESULTS: Patients with primary SS and patients with SLE had a similar immunologic architecture despite having different clinical presentations and prognoses. Stratification of the combined primary SS, SLE, and SLE/SS patient cohorts by K-means cluster analysis revealed 2 endotypes, characterized by distinct immune cell profiles spanning the diagnoses. A signature of 8 T cell subsets that distinctly differentiated the 2 endotypes with high accuracy (area under the curve 0.9979) was identified in logistic regression and machine learning models. In clinical trajectory analyses, the change in damage scores and disease activity levels from baseline to 5 years differed between the 2 endotypes. CONCLUSION: These findings identify an immune cell toolkit that may be useful for differentiating, with high accuracy, the immunologic profiles of patients with primary SS and patients with SLE as a way to achieve targeted therapeutic approaches.
引用
- Martin-Gutierrez L, Peng J, Thompson NL, et al. Stratification of Patients With Sjögren's Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic Implications. Arthritis Rheumatol. 2021. PMID: 33645922. doi:10.1002/art.41708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。